172 related articles for article (PubMed ID: 7794301)
21. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
Costa S; Sideri M; Syrjänen K; Terzano P; De Nuzzo M; De Simone P; Cristiani P; Finarelli AC; Bovicelli A; Zamparelli A; Bovicelli L
Acta Cytol; 2000; 44(3):310-8. PubMed ID: 10833984
[TBL] [Abstract][Full Text] [Related]
22. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Borgatta L; Buck H; Kramer L; Rubin R
J Fam Pract; 1998 Feb; 46(2):125-34. PubMed ID: 9487318
[TBL] [Abstract][Full Text] [Related]
23. Management of the mildly abnormal Pap smear: a conservative approach.
Brown MS; Phillips GL
Gynecol Oncol; 1985 Oct; 22(2):149-53. PubMed ID: 2996992
[TBL] [Abstract][Full Text] [Related]
24. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results.
Lin CJ; Lai HC; Wang KH; Hsiung CA; Liu HW; Ding DC; Hsieh CY; Chu TY
Am J Obstet Gynecol; 2011 Jan; 204(1):21.e1-7. PubMed ID: 20833385
[TBL] [Abstract][Full Text] [Related]
25. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
Bandyopadhyay S; Austin RM; Dabbs D; Zhao C
Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities.
Andersson S; Dillner L; Elfgren K; Mints M; Persson M; Rylander E
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):996-1000. PubMed ID: 16167918
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of Papanicolaou test among HIV-infected women.
Anderson JR; Paramsothy P; Heilig C; Jamieson DJ; Shah K; Duerr A;
Clin Infect Dis; 2006 Feb; 42(4):562-8. PubMed ID: 16421802
[TBL] [Abstract][Full Text] [Related]
28. [Prevalence of human papillomavirus infection in Slovenian women with repeated Pap II smears].
Salimović-Besić I; Bokal EV; Poljak M; Kocjan B
Med Arh; 2005; 59(1):47-51. PubMed ID: 15822686
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
Monsonego J; Pintos J; Semaille C; Beumont M; Dachez R; Zerat L; Bianchi A; Franco E
Int J Gynecol Cancer; 2006; 16(2):591-8. PubMed ID: 16681731
[TBL] [Abstract][Full Text] [Related]
30. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
[TBL] [Abstract][Full Text] [Related]
31. Detection of high-grade cervical dysplasia: impact of age and Bethesda system terminology.
Melnikow J; Nuovo J; Paliescheskey M; Stewart GK; Howell L; Green W
Diagn Cytopathol; 1997 Nov; 17(5):321-5. PubMed ID: 9360043
[TBL] [Abstract][Full Text] [Related]
32. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
[TBL] [Abstract][Full Text] [Related]
33. Colposcopy, cytology and histology in the diagnosis of squamous intraepithelial lesions of the cervix.
Carta G; Di Stefano L; Catellani Perelli A; Toro G; Moscarini M
Clin Exp Obstet Gynecol; 1999; 26(2):60-6. PubMed ID: 10459438
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy.
Ozsaran AA; Ateş T; Dikmen Y; Zeytinoglu A; Terek C; Erhan Y; Ozacar T; Bilgiç A
Eur J Gynaecol Oncol; 1999; 20(2):127-30. PubMed ID: 10376431
[TBL] [Abstract][Full Text] [Related]
35. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
36. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
37. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
Levi AW; Kelly DP; Rosenthal DL; Ronnett BM
Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Woodward L
J Fam Pract; 1998 Feb; 46(2):136-41. PubMed ID: 9487319
[TBL] [Abstract][Full Text] [Related]
39. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing?
Liman AK; Giampoli EJ; Bonfiglio TA
Cancer; 2005 Dec; 105(6):457-60. PubMed ID: 16104044
[TBL] [Abstract][Full Text] [Related]
40. Women's triage and management preferences for cervical cytologic reports demonstrating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
Ferris DG; Kriegel D; Cote L; Litaker M; Woodward L
Arch Fam Med; 1997; 6(4):348-53. PubMed ID: 9225706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
